1. Home
  2. IZEA vs CRVO Comparison

IZEA vs CRVO Comparison

Compare IZEA & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

HOLD

Current Price

$4.41

Market Cap

78.8M

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$7.86

Market Cap

78.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IZEA
CRVO
Founded
2006
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.8M
78.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IZEA
CRVO
Price
$4.41
$7.86
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$21.50
AVG Volume (30 Days)
55.7K
45.1K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,176,492.00
$6,159,786.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.12
N/A
52 Week Low
$1.68
$1.92
52 Week High
$5.86
$16.94

Technical Indicators

Market Signals
Indicator
IZEA
CRVO
Relative Strength Index (RSI) 38.97 46.77
Support Level $4.30 $7.43
Resistance Level $4.74 $8.46
Average True Range (ATR) 0.17 0.52
MACD -0.01 -0.05
Stochastic Oscillator 15.00 47.62

Price Performance

Historical Comparison
IZEA
CRVO

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: